Intrepid Research

Cincinnati, Ohio 95242

3 studies enrolling now · 25 studies all time

What they study most

Cataplexy Narcolepsy, Excessive Daytime Sleepiness, Healthy Volunteers, Hypersomnia, Hypertension, Idiopathic Hypersomnia, Insomnia, Narcolepsy, Narcolepsy Type 1, Narcolepsy Type 1 (NT 1), Narcolepsy Type 1 (NT1), Narcolepsy Type 2

Studies at this site

• DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea. — Recruiting now
• A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions — Recruiting now
• A Study of Retatrutide (LY3437943) in Participants With Type 2 Diabetes Mellitus Who Have Obesity or Overweight — Completed
• RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA — Completed
• Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension — Running, not enrolling
• Study of SDX in Patients With Idiopathic Hypersomnia (IH) — Completed
• A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH — Starting soon
• Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy — Completed
• A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Standardized Antihypertensive Medication Regimen — Completed
• A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic Hypersomnia or Narcolepsy — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 2 — Completed
• A Study of TAK-861 in Participants With Narcolepsy Type 1 — Completed
• Study of the Resvent RXiBreeze™ PAP System to Treat Obstructive Sleep Apnea — Completed
• Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) — Completed
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• Targeted Hypoglossal Neurostimulation Study #3 — Completed
• A Study of TAK-994 in Adults With Narcolepsy — Stopped early
• Trial of AD113 and Atomoxetine in OSA Patients With Hypertension — Completed
• An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy — Completed
• Parallel Arm Trial of AD109 and AD504 In Patients With OSA — Completed
• Four-week Study of the Safety and Efficacy of NLS-2 (Mazindol Extended Release) in the Treatment of Narcolepsy — Completed
• A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension — Completed
• Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants — Completed
• A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy — Completed
• A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia — Status unconfirmed